查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599270

動物/牲畜疫苗市場：按類型、疾病、技術分類 - 2025-2030 年全球預測

Veterinary/Animal Vaccines Market by Type (Aquaculture Vaccine, Companion Animal Vaccine, Livestock Vaccine), Disease (Aquaculture, Companion Animal, Livestock), Technology - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年動物/牲畜疫苗市值為89.6億美元，預計2024年將達到95.8億美元，複合年成長率為6.94%，2030年將達到143.4億美元，預計將達到1000萬美元。

動物/牲畜疫苗市場是動物保健產業的重要組成部分，重點是透過疫苗接種預防動物感染疾病。這些疫苗對於確保牲畜、寵物和野生動物的健康和生產力、支持糧食安全、公共衛生和經濟效益至關重要。獸用疫苗在預防通用感染疾病、改善動物福利、減少對抗生素的依賴以及解決抗菌素抗藥性問題方面的作用凸顯了對獸用疫苗的需求。應用範圍從牛、雞和豬等牲畜到貓狗等伴同性動物，主要最終用途部門為牲畜、獸醫醫院和研究設施。

主要市場統計
基準年[2023] 89.6億美元
預測年份 [2024] 95.8億美元
預測年份 [2030] 143.4億美元
複合年成長率（%） 6.94%

關鍵的成長要素包括對動物性蛋白質的需求增加、寵物擁有率上升以及對動物福利和疾病預防的日益關注。此外，政府促進疫苗接種的舉措以及用於開發新疫苗（例如 DNA 疫苗和重組疫苗）的生物技術進步也對市場擴張做出了重大貢獻。潛在的商機來自於提高意識和對研發的投資，旨在創造更有效、負擔得起且易於管理的疫苗。利用這些機會的研究包括投資創新研究、加強分銷網路以及關注都市化和可支配收入不斷提高的新興市場。

然而，嚴格的監管要求、疫苗市場開拓的高成本以及某些地區缺乏意識等挑戰正在阻礙市場成長。穩定性和儲存問題，加上新興經濟體有限的低溫運輸，也是主要障礙。所需的創新和研究領域包括開發耐熱疫苗、口服疫苗和奈米顆粒疫苗等替代遞送系統，以及增強免疫反應的新型佐劑。了解競爭格局、監管格局和消費者偏好對於尋求發展的企業至關重要。市場往往是動態的，不斷的技術創新和監管變化塑造著市場的演變，帶來挑戰和新的成長機會。

市場動態：快速發展的獸藥/牲畜疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變動物/牲畜疫苗市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 飼養的伴同性動物和牲畜數量增加
    • 改善經濟國家的獸醫醫療設施
    • 動物慢性病和意外傷害發生率增加
  • 市場限制因素
    • 疫苗儲存成本高
  • 市場機會
    • 加大獸用疫苗研發投入
    • 增加寵物保險的可用性
  • 市場挑戰
    • 監測和報告系統不足

波特的五力戰略工具駕馭動物/牲畜疫苗市場

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解獸用/牲畜疫苗市場的外部影響

外部宏觀環境因素在塑造動物/家畜疫苗市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解動物/牲畜疫苗市場的競爭狀況

動物/牲畜疫苗市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣獸醫/牲畜疫苗市場供應商的績效評估

FPNV 定位矩陣是評估動物/牲畜疫苗市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了獸藥/牲畜疫苗市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對動物/牲畜疫苗市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 飼養寵物和牲畜的數量增加
      • 改善經濟中的獸醫護理設施
      • 動物慢性病和意外傷害發生率增加
    • 抑制因素
      • 疫苗儲存成本高
    • 機會
      • 加大獸用疫苗研發投入
      • 擴大寵物保險的保障範圍
    • 任務
      • 監測和報告系統不足
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章動物/牲畜疫苗市場：依類型

  • 水產養殖疫苗
  • 寵物疫苗
  • 牲畜疫苗
  • 豬疫苗
  • 家禽疫苗

第7章動物/牲畜疫苗市場：依疾病分類

  • 水產養殖
  • 寵物
  • 家畜
  • 豬肉
  • 家禽

第8章動物/牲畜疫苗市場：依技術分類

  • 去活化疫苗
  • 減毒活疫苗
  • 重組疫苗
  • 類毒素疫苗

第9章美洲動物/牲畜疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太動物/牲畜疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲/中東/非洲動物/家畜疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Aptimmune Biologics, Inc.
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • Ceva Sante Animale
  • China Animal Husbandry Industry Co., Ltd
  • Elanco AB
  • Endovac Animal Health
  • Heska Corporation
  • Hester Biosciences Limited
  • HIPRA, SA
  • IDT Biologika GmbH
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • Torigen Pharmaceuticals Inc.
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-034B500303A8

The Veterinary/Animal Vaccines Market was valued at USD 8.96 billion in 2023, expected to reach USD 9.58 billion in 2024, and is projected to grow at a CAGR of 6.94%, to USD 14.34 billion by 2030.

The veterinary/animal vaccines market is a crucial segment within the larger animal healthcare industry, focused on preventing infectious diseases among animals through immunization. These vaccines are essential for ensuring the health and productivity of livestock, pets, and wildlife, thus supporting food security, public health, and economic interest. The necessity of animal vaccines is underscored by their role in preventing zoonotic diseases, enhancing animal welfare, and decreasing the reliance on antibiotics, which aids in addressing antimicrobial resistance concerns. Application spans from livestock such as cattle, poultry, and swine to companion animals like cats and dogs, with their primary end-use sectors being animal husbandry, veterinary clinics, and research facilities.

KEY MARKET STATISTICS
Base Year [2023] USD 8.96 billion
Estimated Year [2024] USD 9.58 billion
Forecast Year [2030] USD 14.34 billion
CAGR (%) 6.94%

Key growth factors include increasing demand for animal protein, rising pet ownership, and a heightened focus on animal welfare and disease prevention. Additionally, government initiatives to promote vaccination and advancements in biotechnology for developing novel vaccines like DNA or recombinant vaccines contribute significantly to market expansion. Potential opportunities arise from the growing awareness and investment in research and development, aiming to create more effective, affordable, and easily administrable vaccines. Recommendations to capitalize on these opportunities include investing in innovative research, enhancing distribution networks, and focusing on emerging markets with increasing urbanization and disposable incomes.

However, market growth is challenged by factors like stringent regulatory requirements, high costs associated with vaccine development, and a lack of awareness in certain regions. Stability and storage issues, coupled with limited cold chain infrastructure in developing economies, also pose significant barriers. Areas ripe for innovation and research include developing thermostable vaccines, alternative delivery systems such as oral or nanoparticle-based vaccines, and novel adjuvants to enhance immune responses. Understanding the competitive and regulatory landscape, along with consumer preferences, is critical for businesses aiming for growth. The market tends to be dynamic, with continuous innovations and regulatory changes shaping its evolution and presenting both challenges and novel growth opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary/Animal Vaccines Market

The Veterinary/Animal Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of companion animal and livestock ownership
    • Improving veterinary care facilities in economies
    • Rising incidence of chronic diseases and accidental injuries in animals
  • Market Restraints
    • High storage costs for vaccines
  • Market Opportunities
    • Rising investments in veterinary vaccine R&D
    • Growing availability of pet insurance
  • Market Challenges
    • Inadequate surveillance and reporting systems

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary/Animal Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary/Animal Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary/Animal Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary/Animal Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary/Animal Vaccines Market

A detailed market share analysis in the Veterinary/Animal Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary/Animal Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary/Animal Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary/Animal Vaccines Market

A strategic analysis of the Veterinary/Animal Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary/Animal Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aptimmune Biologics, Inc., Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd, Elanco AB, Endovac Animal Health, Heska Corporation, Hester Biosciences Limited, HIPRA, S.A., IDT Biologika GmbH, Indian Immunologicals Ltd., Merck & Co., Inc., Phibro Animal Health Corporation, Torigen Pharmaceuticals Inc., Virbac SA, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary/Animal Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Aquaculture Vaccine, Companion Animal Vaccine, Livestock Vaccine, Porcine Vaccine, and Poultry Vaccine.
  • Based on Disease, market is studied across Aquaculture, Companion Animal, Livestock, Porcine, and Poultry.
  • Based on Technology, market is studied across Inactivated Vaccine, Live Attenuated Vaccine, Recombinant Vaccine, and Toxoid Vaccine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of companion animal and livestock ownership
      • 5.1.1.2. Improving veterinary care facilities in economies
      • 5.1.1.3. Rising incidence of chronic diseases and accidental injuries in animals
    • 5.1.2. Restraints
      • 5.1.2.1. High storage costs for vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising investments in veterinary vaccine R&D
      • 5.1.3.2. Growing availability of pet insurance
    • 5.1.4. Challenges
      • 5.1.4.1. Inadequate surveillance and reporting systems
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary/Animal Vaccines Market, by Type

  • 6.1. Introduction
  • 6.2. Aquaculture Vaccine
  • 6.3. Companion Animal Vaccine
  • 6.4. Livestock Vaccine
  • 6.5. Porcine Vaccine
  • 6.6. Poultry Vaccine

7. Veterinary/Animal Vaccines Market, by Disease

  • 7.1. Introduction
  • 7.2. Aquaculture
  • 7.3. Companion Animal
  • 7.4. Livestock
  • 7.5. Porcine
  • 7.6. Poultry

8. Veterinary/Animal Vaccines Market, by Technology

  • 8.1. Introduction
  • 8.2. Inactivated Vaccine
  • 8.3. Live Attenuated Vaccine
  • 8.4. Recombinant Vaccine
  • 8.5. Toxoid Vaccine

9. Americas Veterinary/Animal Vaccines Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Veterinary/Animal Vaccines Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Veterinary/Animal Vaccines Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aptimmune Biologics, Inc.
  • 2. Biogenesis Bago SA
  • 3. Boehringer Ingelheim International GmbH
  • 4. Brilliant Bio Pharma Private Limited
  • 5. Ceva Sante Animale
  • 6. China Animal Husbandry Industry Co., Ltd
  • 7. Elanco AB
  • 8. Endovac Animal Health
  • 9. Heska Corporation
  • 10. Hester Biosciences Limited
  • 11. HIPRA, S.A.
  • 12. IDT Biologika GmbH
  • 13. Indian Immunologicals Ltd.
  • 14. Merck & Co., Inc.
  • 15. Phibro Animal Health Corporation
  • 16. Torigen Pharmaceuticals Inc.
  • 17. Virbac SA
  • 18. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY/ANIMAL VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY/ANIMAL VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VETERINARY/ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VETERINARY/ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY/ANIMAL VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY/ANIMAL VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY AQUACULTURE VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMAL VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PORCINE VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY POULTRY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. VETERINARY/ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. VETERINARY/ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023